Patents by Inventor Michael Eugene KOPACH

Michael Eugene KOPACH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR PREPARING A GLP-1/GLUCAGON DUAL AGONIST
    Publication number: 20230220000
    Abstract: The present invention provides processes and compounds for the preparation of glucagon and GLP-1 co-agonist compounds that are useful in the treatment of type 2 diabetes, obesity, nonalcoholic fatty liver disease (NAFLD) and/or nonalcoholic steatohepatitis (NASH).
    Type: Application
    Filed: June 11, 2021
    Publication date: July 13, 2023
    Inventors: Michael Edward KOBIERSKI, Michael Eugene KOPACH
  • METHODS OF MAKING INCRETIN ANALOGS
    Publication number: 20220411461
    Abstract: Intermediate compounds are disclosed for making incretin analogs, or pharmaceutically acceptable salts thereof. In addition, methods are disclosed for making incretin analogs by coupling from two to four of the intermediate compounds herein via hybrid liquid solid phase synthesis or native chemical ligation.
    Type: Application
    Filed: August 18, 2020
    Publication date: December 29, 2022
    Inventors: Michael Eugene Kopach, Yu Lu, Sergey Vladimirovich Tsukanov, Timothy Donald White, Ankur Jalan, Jinju James, Michael E. Kobierski
  • PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST
    Publication number: 20220135639
    Abstract: The present invention provides novel intermediates and processes useful in the manufacture of tirzepatide, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 28, 2020
    Publication date: May 5, 2022
    Inventors: Stephanie Ruth COFFIN, Michael Oliver FREDERICK, Ankur JALAN, Neil John KALLMAN, Michael Eugene KOPACH, Kevin Dale SEIBERT, Sergey Vladimirovich TSUKANOV